Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Seehofer

Showing results (281-290 of 310) with videos related to

Pageof 31
Sort By:
Toxicology Letters|August 13, 2022
In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assayTim Brecklinghaus, Wiebke Albrecht, Julia Duda, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2024
Deceased donor urinary Dickkopf-3 associates with future allograft function following kidney transplantationJonathan de Fallois, Anna Günzel, Christoph Daniel, et al.
Nature Communications|October 10, 2018
Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic controlMario Brosch, Kathrin Kattler, Alexander Herrmann, et al.
BMC Cancer|April 13, 2012
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trialCarl Christoph Schimanski, Markus Möhler, Michael Schön, et al.
Cell Systems|November 11, 2025
Diclofenac and acetaminophen dim the acute-phase response but amplify expression of the iron regulator hepcidin in liver cancer cellsAnja Zeilfelder, Joep Vanlier, Christina Mölders, et al.
Frontiers in Oncology|November 4, 2022
Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001)Moritz Schmelzle, Christian Benzing, Lutz Fischer, et al.
Transplantation|July 12, 2018
Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular CarcinomaNils Heits, Mario Brosch, Alexander Herrmann, et al.
Cell Reports|August 25, 2021
Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluriaKathrin Gianmoena, Nina Gasparoni, Adelina Jashari, et al.
Frontiers in Physiology|October 25, 2017
Model Based Targeting of IL-6-Induced Inflammatory Responses in Cultured Primary Hepatocytes to Improve Application of the JAK Inhibitor RuxolitinibSvantje Sobotta, Andreas Raue, Xiaoyun Huang, et al.
Archives of Toxicology|June 25, 2016
Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissuePatricio Godoy, Agata Widera, Wolfgang Schmidt-Heck, et al.
Pageof 31

Showing results (281-290 of 310) with videos related to

Sort By:
Pageof 31
Toxicology Letters|August 13, 2022
In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assayTim Brecklinghaus, Wiebke Albrecht, Julia Duda, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2024
Deceased donor urinary Dickkopf-3 associates with future allograft function following kidney transplantationJonathan de Fallois, Anna Günzel, Christoph Daniel, et al.
Nature Communications|October 10, 2018
Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic controlMario Brosch, Kathrin Kattler, Alexander Herrmann, et al.
BMC Cancer|April 13, 2012
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trialCarl Christoph Schimanski, Markus Möhler, Michael Schön, et al.
Cell Systems|November 11, 2025
Diclofenac and acetaminophen dim the acute-phase response but amplify expression of the iron regulator hepcidin in liver cancer cellsAnja Zeilfelder, Joep Vanlier, Christina Mölders, et al.
Frontiers in Oncology|November 4, 2022
Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001)Moritz Schmelzle, Christian Benzing, Lutz Fischer, et al.
Transplantation|July 12, 2018
Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular CarcinomaNils Heits, Mario Brosch, Alexander Herrmann, et al.
Cell Reports|August 25, 2021
Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluriaKathrin Gianmoena, Nina Gasparoni, Adelina Jashari, et al.
Frontiers in Physiology|October 25, 2017
Model Based Targeting of IL-6-Induced Inflammatory Responses in Cultured Primary Hepatocytes to Improve Application of the JAK Inhibitor RuxolitinibSvantje Sobotta, Andreas Raue, Xiaoyun Huang, et al.
Archives of Toxicology|June 25, 2016
Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissuePatricio Godoy, Agata Widera, Wolfgang Schmidt-Heck, et al.
Pageof 31